thyroxine has been researched along with Benign Intracranial Hypertension in 18 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
| Excerpt | Relevance | Reference |
|---|---|---|
| " It has been reported to occur in hypothyroidism, particularly after the initiation of L-thyroxine replacement therapy." | 7.69 | Pseudotumor cerebri in an infant after L-thyroxine therapy for transient neonatal hypothyroidism. ( DiMartino-Nardi, J; Linder, B; Raghavan, S; Saenger, P, 1997) |
| " It has been reported to occur in hypothyroidism, particularly after the initiation of L-thyroxine replacement therapy." | 3.69 | Pseudotumor cerebri in an infant after L-thyroxine therapy for transient neonatal hypothyroidism. ( DiMartino-Nardi, J; Linder, B; Raghavan, S; Saenger, P, 1997) |
| " We report what we believe is a new association following initiation of thyroxine (T4) replacement in hypothalamic hypothyroidism, as well as another occurrence following T4 replacement in primary hypothyroidism." | 3.67 | Pseudotumor cerebri following treatment of hypothalamic and primary hypothyroidism. ( Huseman, CA; Torkelson, RD, 1984) |
| "The pseudotumor cerebri, a neurological syndrome clinically characterized by headaches, vomiting and bilateral papilledema, occurred in two patients, previously subjected to total thyroidectomy for differentiated thyroid carcinoma, after initiation of levothyroxine replacement therapy." | 3.67 | Pseudotumor cerebri and thyroid-replacement therapy in patients affected by differentiated thyroid carcinoma. ( De Rosa, M; Lombardi, G; Panza, N; Salvatore, M, 1985) |
| "The adverse health effects of thyrotoxicosis have been carefully documented and most practitioners are familiar with the clinical consequences for the patient." | 2.40 | Adverse effects of thyroid hormones. ( Williams, JB, 1997) |
| "To report a case of benign intracranial hypertension occurring during thyreostimulin suppression hormonotherapy after thyroidectomy for papillary cancer." | 1.31 | Benign intracranial hypertension and thyreostimulin suppression hormonotherapy. ( Conrath, J; Disdier, P; Dufour, H; Granel, B; Henry, JF; Serratrice, J; Weiller, PJ, 2002) |
| "A 12-year-old girl presented with primary hypothyroidism, secondary pituitary hyperplasia, and intracranial hypertension." | 1.29 | Primary hypothyroidism with intracranial hypertension and pituitary hyperplasia. ( Adams, C; Dean, HJ; Fewer, DH; Israels, SJ; Patton, A, 1994) |
| "A male patient is reported with benign intracranial hypertension, who presented with three periods of partial pituitary deficiency, corresponding to episodes of headaches and papilledema." | 1.29 | Benign intracranial hypertension as a cause of transient partial pituitary deficiency. ( Abs, R; Clemens, A; De Paepe, L; Louis, P; Martin, JJ; Smets, RM; Verlooy, J, 1993) |
| "Over recent years empty sella turcica has become more frequently diagnosed with high resolution computerized tomography and the associated clinical abnormalities have been better described." | 1.27 | Clinical spectrum of primary empty sella turcica. ( Alford, FP; Best, JD; Gilford, EJ; Henderson, JK; Murphy, MA; Ramos, RF, 1988) |
| "The syndrome of benign intracranial hypertension cannot therefore be considered entirely benign and patients should receive full endocrinological assessment and follow up." | 1.26 | Is "benign intracranial hypertension" really benign? ( Barber, SG; Garvan, N, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (55.56) | 18.7374 |
| 1990's | 6 (33.33) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Serratrice, J | 1 |
| Granel, B | 1 |
| Conrath, J | 1 |
| Dufour, H | 1 |
| Disdier, P | 1 |
| Henry, JF | 1 |
| Weiller, PJ | 1 |
| Frost, N | 1 |
| Lee, MS | 1 |
| Sweeney, P | 1 |
| Huseman, CA | 1 |
| Torkelson, RD | 1 |
| McVie, R | 1 |
| Barber, SG | 1 |
| Garvan, N | 1 |
| Van Dop, C | 2 |
| Conte, FA | 1 |
| Koch, TK | 1 |
| Clark, SJ | 1 |
| Wilson-Davis, SL | 1 |
| Grumbach, MM | 1 |
| Campos, SP | 1 |
| Olitsky, S | 1 |
| Adams, C | 1 |
| Dean, HJ | 1 |
| Israels, SJ | 1 |
| Patton, A | 1 |
| Fewer, DH | 1 |
| De Paepe, L | 1 |
| Abs, R | 1 |
| Verlooy, J | 1 |
| Clemens, A | 1 |
| Smets, RM | 1 |
| Louis, P | 1 |
| Martin, JJ | 1 |
| Bermúdez de la Vega, JA | 1 |
| Martínez Martínez, JJ | 1 |
| Fernández Fiscer, P | 1 |
| González Hachero, J | 1 |
| Raghavan, S | 1 |
| DiMartino-Nardi, J | 1 |
| Saenger, P | 1 |
| Linder, B | 1 |
| Williams, JB | 1 |
| Prendes, JL | 1 |
| McLean, WT | 1 |
| Murphy, MA | 1 |
| Ramos, RF | 1 |
| Henderson, JK | 1 |
| Gilford, EJ | 1 |
| Alford, FP | 1 |
| Best, JD | 1 |
| Rohn, R | 1 |
| Panza, N | 1 |
| De Rosa, M | 1 |
| Lombardi, G | 1 |
| Salvatore, M | 1 |
3 reviews available for thyroxine and Benign Intracranial Hypertension
| Article | Year |
|---|---|
Idiopathic intracranial hypertension after L-thyroxine therapy for acquired primary hypothyroidism.
Topics: Acetazolamide; Child; Dose-Response Relationship, Drug; Female; Humans; Hypothyroidism; Pseudotumor | 1995 |
[Benign intracranial hypertension as a secondary effect of treatment with a biosynthetic growth hormone].
Topics: Child; Drug Therapy, Combination; Growth Hormone; Humans; Hypopituitarism; Male; Pseudotumor Cerebri | 1996 |
Adverse effects of thyroid hormones.
Topics: Aging; Cardiovascular Diseases; Clinical Trials as Topic; Euthyroid Sick Syndromes; Female; Humans; | 1997 |
15 other studies available for thyroxine and Benign Intracranial Hypertension
| Article | Year |
|---|---|
Benign intracranial hypertension and thyreostimulin suppression hormonotherapy.
Topics: Adenocarcinoma, Papillary; Drug Therapy, Combination; Female; Glycoproteins; Humans; Middle Aged; Pa | 2002 |
Myxedema, papilledema, and elevated CSF protein.
Topics: Acetazolamide; Anemia, Pernicious; Cerebrospinal Fluid Proteins; Confusion; Diagnosis, Differential; | 2004 |
Pseudotumor cerebri following treatment of hypothalamic and primary hypothyroidism.
Topics: Adolescent; Empty Sella Syndrome; Female; Fundus Oculi; Humans; Hypothalamic Diseases; Hypothyroidis | 1984 |
Abnormal TSH regulation, pseudotumor cerebri, and empty sella after replacement therapy in juvenile hypothyroidism.
Topics: Adolescent; Empty Sella Syndrome; Female; Humans; Hypothyroidism; Pseudotumor Cerebri; Thyrotropin; | 1984 |
Is "benign intracranial hypertension" really benign?
Topics: Adult; Blood Glucose; Estradiol; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Hydro | 1980 |
Pseudotumor cerebri associated with initiation of levothyroxine therapy for juvenile hypothyroidism.
Topics: Autoantibodies; Autoimmune Diseases; Child; Female; Humans; Hypothyroidism; Male; Pseudotumor Cerebr | 1983 |
Pseudotumor cerebri and thyroid-replacement therapy.
Topics: Child; Female; Humans; Hypothyroidism; Male; Pseudotumor Cerebri; Thyroxine | 1983 |
Primary hypothyroidism with intracranial hypertension and pituitary hyperplasia.
Topics: Cerebrospinal Fluid Pressure; Child; Dexamethasone; Diagnosis, Differential; Female; Humans; Hyperpl | 1994 |
Benign intracranial hypertension as a cause of transient partial pituitary deficiency.
Topics: Adult; Follicle Stimulating Hormone; Hormones; Humans; Hypopituitarism; Intracranial Pressure; Lutei | 1993 |
Pseudotumor cerebri in an infant after L-thyroxine therapy for transient neonatal hypothyroidism.
Topics: Congenital Hypothyroidism; Female; Humans; Hypothyroidism; Infant, Newborn; Pseudotumor Cerebri; Thy | 1997 |
Pseudotumor cerebri during treatment for hypothyroidism.
Topics: Child; Female; Humans; Hypothyroidism; Pseudotumor Cerebri; Thyroxine | 1978 |
Clinical spectrum of primary empty sella turcica.
Topics: Adult; Cortisone; Drug Therapy, Combination; Empty Sella Syndrome; Female; Follow-Up Studies; Humans | 1988 |
Alternate causes of pseudotumor cerebri.
Topics: Child; Humans; Hypothyroidism; Pseudotumor Cerebri; Thyroxine | 1985 |
Pseudotumor cerebri following treatment of hypothyroidism.
Topics: Child; Female; Humans; Hypothyroidism; Pseudotumor Cerebri; Thyroxine | 1985 |
Pseudotumor cerebri and thyroid-replacement therapy in patients affected by differentiated thyroid carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Brain Neoplasms; Carcinoma, Papillary; Diagnosis, Differential; Humans; | 1985 |